New HIV treatment cost worries health experts.
| dc.contributor.author | Mafabi, David | |
| dc.date.accessioned | 2026-06-01T13:45:12Z | |
| dc.date.available | 2026-06-01T13:45:12Z | |
| dc.date.issued | 2017-08-21 | |
| dc.description | Newspaper articles | |
| dc.description.abstract | KAMPALA. Although Uganda started the potent combination antiretroviral (ARV) therapy for treatment of HIV in 2004 that remarkably reduced Hiv related mortality, the increasing emergency of drug resistance, could challenge this achievement, health workers have warned. | |
| dc.identifier.citation | Mafabi, D. (2017). New HIV treatment cost worries health experts. Daily Monitor. | |
| dc.identifier.uri | https://bdears.busitema.ac.ug/handle/123456789/4369 | |
| dc.language.iso | en | |
| dc.publisher | Daily Monitor | |
| dc.title | New HIV treatment cost worries health experts. | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Mafabi-David-DM-21-08-2017.pdf
- Size:
- 1.58 MB
- Format:
- Adobe Portable Document Format
- Description:
- Newspaper article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: